Welcome & Introduction

Program: CMES Ancillary Events
Session: CMES2-Applying the Evidence for GLP-1 Receptor Agonists in Type 2 Diabetes: Practice Perspectives
Supported by an educational grant from AstraZeneca
Friday, March 6, 2015: 5:45 AM-8:00 AM
Presentation Start Time: 6:00 AM
Sapphire B (Hilton San Diego Bayfront)
Silvio E Inzucchi, MD
Yale School of Medicine, New Haven, CT

Disclosure: SEI: Planning Group Member, Merck & Co., Committee Member, Novo Nordisk, Scientific Board Member, Boehringer-Ingelheim, Research Materials, Takeda, Speaker, Astra Zeneca, Scientific Board Member, Eisai, Scientific Board Member, Lexicon Pharmaceuticals, Inc., Committee Member, Intarcia.